Effect of semaglutide versus other glucagon-like peptide-1 receptor agonists on cardio-metabolic risk factors in patients with type 2 diabetes: A systematic review and meta-analysis of head-to-head, phase 3, randomized controlled trials
Dimitrios Patoulias, Djordje S. Popovic, Anca Pantea Stoian, Andrej Janež, Amirhossein Sahebkar, Manfredi Rizzo
Topics & Concepts
SemaglutideMedicineDiabetes mellitusGlucagon-like peptide 1 receptorGlucagon-like peptide-1Internal medicineType 2 diabetesMeta-analysisExenatideHead (geology)EndocrinologyReceptorLiraglutideAgonistGeomorphologyGeologyDiabetes Treatment and ManagementBariatric Surgery and OutcomesHyperglycemia and glycemic control in critically ill and hospitalized patients